GB9911456D0 - Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives - Google Patents

Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives

Info

Publication number
GB9911456D0
GB9911456D0 GBGB9911456.3A GB9911456A GB9911456D0 GB 9911456 D0 GB9911456 D0 GB 9911456D0 GB 9911456 A GB9911456 A GB 9911456A GB 9911456 D0 GB9911456 D0 GB 9911456D0
Authority
GB
United Kingdom
Prior art keywords
pyridofurane
oligohydroxyl
benzofurane
urea
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9911456.3A
Other versions
GB2350111A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GB9911456A priority Critical patent/GB2350111A/en
Publication of GB9911456D0 publication Critical patent/GB9911456D0/en
Priority to PCT/EP2000/004016 priority patent/WO2000069844A1/en
Priority to AU49170/00A priority patent/AU4917000A/en
Publication of GB2350111A publication Critical patent/GB2350111A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GB9911456A 1999-05-17 1999-05-17 Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives Withdrawn GB2350111A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9911456A GB2350111A (en) 1999-05-17 1999-05-17 Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
PCT/EP2000/004016 WO2000069844A1 (en) 1999-05-17 2000-05-04 Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors
AU49170/00A AU4917000A (en) 1999-05-17 2000-05-04 Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9911456A GB2350111A (en) 1999-05-17 1999-05-17 Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives

Publications (2)

Publication Number Publication Date
GB9911456D0 true GB9911456D0 (en) 1999-07-14
GB2350111A GB2350111A (en) 2000-11-22

Family

ID=10853623

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9911456A Withdrawn GB2350111A (en) 1999-05-17 1999-05-17 Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives

Country Status (3)

Country Link
AU (1) AU4917000A (en)
GB (1) GB2350111A (en)
WO (1) WO2000069844A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
EP1478639A1 (en) 2002-02-22 2004-11-24 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
SG156650A1 (en) 2004-07-16 2009-11-26 Sunesis Pharmaceuticals Inc Thienopyrimidines useful as aurora kinase inhibitors
JP6106179B2 (en) * 2012-02-24 2017-03-29 武田薬品工業株式会社 Aromatic ring compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9410877D0 (en) * 1994-05-31 1994-07-20 Bayer Ag Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes

Also Published As

Publication number Publication date
AU4917000A (en) 2000-12-05
GB2350111A (en) 2000-11-22
WO2000069844A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
DE60018571D1 (en) Hernienprothese
DE60008112D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE60008382D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE60037335D1 (en) Polymerizationsverfahren
DE50008011D1 (en) Thixotropierungsmittel
DE60018288D1 (en) Polyphenylensulfidlegierungszusammensetzung
DE50002614D1 (en) Sigma-delta-modulator
DE60007505D1 (en) Propargyletherderivate
DE50000137D1 (en) Spirofluorenopyrane
DE60011809D1 (en) Oxcarbazepinsuspension
DE59909975D1 (en) Testleck
DE10081629D2 (en) Seilzugbefestigung
DE50009469D1 (en) Common-rail-injektor
DE60012950D1 (en) Polyacetalharzzusammensetzung
DE60001313D1 (en) Imidazodiazepinderivate
DE50010757D1 (en) Stilbenaufheller
HK1048307A1 (en) Substituted heterocyclyl-2h-chromenes
GB9911452D0 (en) Benzofuranylsulfonates
GB9912097D0 (en) E-Pen
DE50008218D1 (en) Common-rail-injektor
DE60026282D1 (en) Photovervielfacherröhre
DE50012999D1 (en) Stirnwandisolation
DE60004080D1 (en) Centroidintegration
DE60012212D1 (en) Orthotopisches totalkunstherz

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)